Passage Bio, Inc. (PASG)
4.43
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 11:11
Passage Bio Cash from Operations (TTM) : -33.50M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -33.50M |
| March 31, 2026 | -30.65M |
| December 31, 2025 | -31.51M |
| September 30, 2025 | -33.47M |
| June 30, 2025 | -36.07M |
| March 31, 2025 | -42.87M |
| December 31, 2024 | -47.96M |
| September 30, 2024 | -59.03M |
| June 30, 2024 | -70.74M |
| March 31, 2024 | -74.75M |
| December 31, 2023 | -78.26M |
| September 30, 2023 | -82.77M |
| June 30, 2023 | -87.00M |
| March 31, 2023 | -95.94M |
| Date | Value |
|---|---|
| December 31, 2022 | -118.21M |
| September 30, 2022 | -124.96M |
| June 30, 2022 | -142.62M |
| March 31, 2022 | -140.87M |
| December 31, 2021 | -126.88M |
| September 30, 2021 | -125.53M |
| June 30, 2021 | -102.00M |
| March 31, 2021 | -89.39M |
| December 31, 2020 | -80.52M |
| September 30, 2020 | -68.07M |
| June 30, 2020 | -62.47M |
| March 31, 2020 | -61.53M |
| December 31, 2019 | -39.90M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ARS Pharmaceuticals, Inc. | -196.40M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |
| Savara, Inc. | -110.38M |